肝癌患者行肝动脉栓塞化疗的临床分析

Clinical Analysis of Hepatic Arterial Chemoembolization in Patients with Liver Cancer

目的：探究肝癌患者行肝动脉栓塞化疗的临床治疗效果。方法：选取某院2014年7月-2015年8月收治的70例肝癌患者,进行回顾性分析,根据治疗方式的不同随机分为两组,对照组40例,采用常规化疗;观察组30例,采用肝动脉化疗栓塞术,对比分析肝动脉栓塞术对治疗肝癌患者的临床效果。结果：两组患者在症状改善情况和不良反应发生情况的比较上,均是观察组效果更好,差异具有统计学意义（P〈0.05）。结论：肝动脉栓塞化疗（TACE）对肝癌患者进行治疗,对患者症状改善效果较好,同时不良反应相对较低,值得在临床上推广应用。

Objective：To explore the clinical therapeutic effect of hepatic arterial chemoembolization in patients with liver cancer.Methods：70cases of liver cancer patients treated in a hospital from July 2014 to August 2015 were selected and randomly divided into control group（40cases）and observation group（30cases）according to the different treatment methods.The patients in control group were treated with conventional chemotherapy,and the patients in observation group were treated with hepatic arterial chemoembolization.The clinical therapeutic effect of hepatic arterial chemoembolization in patients with liver cancer was analyzed.Results：The improvement of symptoms and adverse reactions of observation group were much better than that of control group,and the difference was statistically significant（P〈0.05）.Conclusion：The improvement of the symptoms of hepatic arterial chemoembolization（TACE）in treatment of patients with liver cancer is good,and the adverse reactions are relatively low,which is worthy of clinical promotion and application.